Skip to main content

Interferon alfa-2b Injection

Last Updated: January 10, 2022
Status: Current

Products Affected - Description
    • Intron A injection, Merck, 10 million units, vial, 1 count, NDC 00085-4350-01
    • Intron A injection, Merck, 18 million units, vial, 1 count, NDC 00085-4351-01
    • Intron A injection, Merck, 50 million units, vial, 1 count, NDC 00085-4352-01
    • Intron A injection, Merck, 10 million units/mL, 2.5 mL vial, 1 count, NDC 00085-1133-01
    • Intron A injection, Merck, 6 million units/mL, 3 mL vial, 1 count, NDC 00085-1168-01
Reason for the Shortage
    • Merck has made a business decision to discontinue all presentations of Intron A.
    • They are the sole suppliers of interferon alfa-2b.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Merck has discontinued all presentations of Intron A solution for injection.
    • Merck has discontinued all presentations of Intron A powder for injection.

Updated

Updated January 10, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 30, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.